Page last updated: 2024-11-03

risperidone and Retinal Artery Occlusion

risperidone has been researched along with Retinal Artery Occlusion in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Retinal Artery Occlusion: Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, J1
Weiter, JJ1

Other Studies

1 other study available for risperidone and Retinal Artery Occlusion

ArticleYear
Branch retinal artery occlusion after injection of a long-acting risperidone preparation.
    Annals of internal medicine, 2007, Aug-21, Volume: 147, Issue:4

    Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Compounding; Humans; Injections; Male

2007